Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Baxter
Cipla
Medtronic
UBS
US Department of Justice
Argus Health
Novartis
QuintilesIMS
Queensland Health

Generated: January 19, 2018

DrugPatentWatch Database Preview

Besifloxacin hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for besifloxacin hydrochloride and what is the scope of besifloxacin hydrochloride patent protection?

Besifloxacin hydrochloride
is the generic ingredient in one branded drug marketed by Bausch And Lomb and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Besifloxacin hydrochloride has fifty-three patent family members in nineteen countries.

There are three drug master file entries for besifloxacin hydrochloride. Three suppliers are listed for this compound.
Summary for besifloxacin hydrochloride
Pharmacology for besifloxacin hydrochloride
Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial

US Patents and Regulatory Information for besifloxacin hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bausch And Lomb BESIVANCE besifloxacin hydrochloride SUSPENSION/DROPS;OPHTHALMIC 022308-001 May 28, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bausch And Lomb BESIVANCE besifloxacin hydrochloride SUSPENSION/DROPS;OPHTHALMIC 022308-001 May 28, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bausch And Lomb BESIVANCE besifloxacin hydrochloride SUSPENSION/DROPS;OPHTHALMIC 022308-001 May 28, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bausch And Lomb BESIVANCE besifloxacin hydrochloride SUSPENSION/DROPS;OPHTHALMIC 022308-001 May 28, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bausch And Lomb BESIVANCE besifloxacin hydrochloride SUSPENSION/DROPS;OPHTHALMIC 022308-001 May 28, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Bausch And Lomb BESIVANCE besifloxacin hydrochloride SUSPENSION/DROPS;OPHTHALMIC 022308-001 May 28, 2009 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for besifloxacin hydrochloride

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,749,970 Topical treatment of prevention of ocular infections ➤ Subscribe
6,239,113 Topical treatment or prevention of ocular infections ➤ Subscribe
6,569,443 Topical treatment or prevention of ocular infections ➤ Subscribe
7,732,415 Topical treatment or prevention of ocular infections ➤ Subscribe
7,056,893 Topical treatment for prevention of ocular infections ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for besifloxacin hydrochloride

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Harvard Business School
UBS
Covington
AstraZeneca
Baxter
Medtronic
Merck
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot